Upper Limb Function and Visuospatial Exploration After Stroke

Assessing Pathological Synergies of Upper Limb Function and the Relationship to Visuospatial Exploration After Stroke

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03135093

Enrollment

Registered

2017-05-01

Start date

2017-04-01

Completion date

2019-12-30

Last updated

2020-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

synergies, upper limb, vision

Brief summary

This project is a cross-sectional, observational mono-center study with prospective data collecting. This study aims to further explore quality of upper limb movement in relation to characteristics of visuospatial exploration in stroke subjects and healthy subjects by a applying comprehensive measurements of clinical scales and kinematic data in capacity- and performance-based activities. The results will contribute to assessing and monitoring quality of upper limb movements and visuospatial attention and their relationship.

Interventions

OTHERNo intervention

No Intervention

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Subjects of 18 years and older with chronic ischemic stroke (\> 6 month) restricted to one hemisphere (confirmed by CT/MRI) * With impairments in upper limb function and at least partial ability to lift the arm against gravity, flex and extend the fingers * Without relevant pre-existing limitations in arm and hand function (orthopaedic, muscular, neurologic) * Written informed consent after participants's information

Exclusion criteria

* Increased muscle tone in the upper limb with limited rang of motion * Severe sensory deficits in the upper limb * Clinically significant concomitant disease (affecting the upper limb or impaired vision, e.g. due to glaucoma etc.) * Contraindications on ethical grounds (vulnerable persons) * Known or suspected non-compliance, drug or alcohol abuse * Severe communication or cognitive deficits, that cause inability to follow the procedures

Design outcomes

Primary

Measure	Time frame	Description
Visuospatial exploration	One day	Eye-tracking data (e.g. area of interest, eye movements: saccades, fixations) and to rule out stroke-related deficits of visuospatial attention, clinical tests
Upper limb movement quality	One day	Fugl-Meyer Assessment of the upper extremity (FMA-UE), kinematic data (e.g. joint angles, hand workspace)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026